T1	PROC 46 70	Estudio de investigación
#1	AnnotatorNotes T1	C0681814; research study; Research Activity
T2	CHEM 85 102	insulina degludec
#2	AnnotatorNotes T2	C3491971; insulin degludec; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance
T3	CHEM 107 123	insulina detemir
#3	AnnotatorNotes T3	C0537270; insulin detemir; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance
T4	CHEM 150 165	insulina aspart
#4	AnnotatorNotes T4	C0123677; insulin aspart, human; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance | C1708521; Insulin Aspart; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance
T5	DISO 194 209	diabetes tipo 1
#5	AnnotatorNotes T5	C0011854; Diabetes Mellitus, Insulin-Dependent; Disease or Syndrome
T6	PROC 232 277	Ensayo para comparar el efecto y la seguridad
T7	CHEM 281 298	insulina degludec
#6	AnnotatorNotes T7	C3491971; insulin degludec; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance
T8	CHEM 308 324	insulina detemir
#7	AnnotatorNotes T8	C0537270; insulin detemir; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance
T9	CHEM 351 366	insulina aspart
#8	AnnotatorNotes T9	C0123677; insulin aspart, human; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance | C1708521; Insulin Aspart; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance
T10	PROC 374 385	tratamiento
#9	AnnotatorNotes T10	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T11	DISO 413 428	diabetes tipo 1
#10	AnnotatorNotes T11	C0011854; Diabetes Mellitus, Insulin-Dependent; Disease or Syndrome
T12	DISO 452 467	Diabetes Tipo 1
#11	AnnotatorNotes T12	C0011854; Diabetes Mellitus, Insulin-Dependent; Disease or Syndrome
T13	DISO 494 519	Diabetes Mellitus, Tipo 1
T14	PROC 635 649	Diagnosticadas
#12	AnnotatorNotes T14	C0011900; Diagnosis; Diagnostic Procedure
T15	DISO 653 677	diabetes mellitus tipo 1
#13	AnnotatorNotes T15	C0011854; Diabetes Mellitus, Insulin-Dependent; Disease or Syndrome
T16	CHEM 777 785	insulina
#14	AnnotatorNotes T16	C0021641; Insulin; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance | C3537244; Insulins; Pharmacologic Substance
T17	PROC 792 832	infusión subcutánea continua de insulina
#15	AnnotatorNotes T17	C0393124; Continuous subcutaneous infusion of insulin; Therapeutic or Preventive Procedure
T18	CHEM 824 832	insulina
#16	AnnotatorNotes T18	C0021641; Insulin; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance | C3537244; Insulins; Pharmacologic Substance
T19	CHEM 846 854	insulina
#17	AnnotatorNotes T19	C0021641; Insulin; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance | C3537244; Insulins; Pharmacologic Substance
T20	PROC 986 1000	aleatorización
#18	AnnotatorNotes T20	C0034656; Randomization; Research Activity
T21	PROC 1028 1041	asesoramiento
#19	AnnotatorNotes T21	C0150600; Advice; Health Care Activity
T22	ANAT 1086 1103	feto intrauterino
T23	PROC 2267 2291	dilatación farmacológica
#20	AnnotatorNotes T23	C1322279; Dilate procedure; Therapeutic or Preventive Procedure (?)
T24	PROC 1180 1194	aleatorización
#21	AnnotatorNotes T24	C0034656; Randomization; Research Activity
T25	PROC 1216 1225	ecografía
#22	AnnotatorNotes T25	C0041618; Ultrasonography; Diagnostic Procedure
T26	PROC 1327 1351	Tratamiento con fármacos
#23	AnnotatorNotes T26	C0013216; Pharmacotherapy; Therapeutic or Preventive Procedure
T27	DISO 1370 1378	diabetes
#24	AnnotatorNotes T27	C0011849; Diabetes Mellitus; Disease or Syndrome | C1802373; Diabetes mellitus (incl subtypes); Disease or Syndrome
T28	DISO 1384 1392	obesidad
#25	AnnotatorNotes T28	C0028754; Obesity; Disease or Syndrome
T29	DISO 1523 1534	proteinuria
#26	AnnotatorNotes T29	C0033687; Proteinuria; Finding
T30	PROC 1621 1637	muestra de orina
T31	CHEM 1571 1580	proteínas
#27	AnnotatorNotes T31	C0033684; Proteins; Amino Acid, Peptide, or Protein · Biologically Active Substance
T32	CHEM 1583 1593	creatinina
#28	AnnotatorNotes T32	C0010294; creatinine; Biologically Active Substance · Organic Chemical
T33	PROC 1683 1694	tratamiento
#29	AnnotatorNotes T33	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T34	PROC 1730 1750	fecundación in vitro
#30	AnnotatorNotes T34	C0015915; Fertilization in Vitro; Therapeutic or Preventive Procedure
T35	PROC 1758 1776	tratamiento médico
#31	AnnotatorNotes T35	C0418981; Medical therapy; Therapeutic or Preventive Procedure
T36	DISO 1785 1797	infertilidad
#32	AnnotatorNotes T36	C0021359; Infertility; Pathologic Function | C0917730; Female sterility; Finding | C4074771; Sterility, Reproductive; Pathologic Function
T37	CHEM 1824 1835	medicamento
#33	AnnotatorNotes T37	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T38	PROC 1972 1986	aleatorización
#34	AnnotatorNotes T38	C0034656; Randomization; Research Activity
T39	PROC 2077 2091	aleatorización
#35	AnnotatorNotes T39	C0034656; Randomization; Research Activity
T40	DISO 2122 2147	Retinopatía proliferativa
#36	AnnotatorNotes T40	C0339467; Proliferative retinopathy; Disease or Syndrome
T41	DISO 2150 2161	maculopatía
#37	AnnotatorNotes T41	C0730362; Disorder of macula of retina; Disease or Syndrome
T42	PROC 2179 2198	tratamiento urgente
T43	ANAT 2243 2246	ojo
#38	AnnotatorNotes T43	C0015392; Eye; Body Part, Organ, or Organ Component | C1280202; Entire eye; Body Part, Organ, or Organ Component
T44	PROC 2249 2262	oftalmoscopia
#39	AnnotatorNotes T44	C0029090; Ophthalmoscopy; Diagnostic Procedure
T45	PROC 2330 2344	aleatorización
#40	AnnotatorNotes T45	C0034656; Randomization; Research Activity
T46	PROC 2407 2421	aleatorización
#41	AnnotatorNotes T46	C0034656; Randomization; Research Activity
T47	DISO 2468 2489	hiperémesis gravídica
#42	AnnotatorNotes T47	C0020450; Hyperemesis Gravidarum; Sign or Symptom
T48	PROC 2514 2529	hospitalización
#43	AnnotatorNotes T48	C0019993; Hospitalization; Health Care Activity
T49	PROC 719 755	Tratadas con inyecciones subcutáneas
T50	PROC 607 631	consentimiento informado
#44	AnnotatorNotes T50	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T51	PROC 834 838	ISCI
T52	PROC 1229 1234	HbA1c
#45	AnnotatorNotes T52	C0202054; Glucohemoglobin measurement; Laboratory Procedure
T53	CHEM 1343 1351	fármacos
#46	AnnotatorNotes T53	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T54	PROC 1556 1602	cociente entre proteínas y creatinina en orina
#47	AnnotatorNotes T54	C1096054; Urine protein/creatinine ratio measurement; Laboratory Procedure
T55	ANAT 1597 1602	orina
#48	AnnotatorNotes T55	C0042036; Urine; Body Substance
T56	ANAT 1632 1637	orina
#49	AnnotatorNotes T56	C0042036; Urine; Body Substance
T57	PROC 2234 2246	fondo de ojo
#50	AnnotatorNotes T57	C0029090; Ophthalmoscopy; Diagnostic Procedure
T58	Date 13 17	2017
T59	LIVB 170 189	mujeres embarazadas
#51	AnnotatorNotes T59	C0033011; Pregnant Women; Population Group
T60	LIVB 389 408	mujeres embarazadas
#52	AnnotatorNotes T60	C0033011; Pregnant Women; Population Group
T61	LIVB 548 555	Mujeres
#53	AnnotatorNotes T61	C0043210; Woman; Population Group
T62	Age 559 568	≥ 18 años
T63	Duration 678 685	≥ 1 año
T64	Route 744 755	subcutáneas
#54	AnnotatorNotes T64	C1522438; Subcutaneous Route of Drug Administration; Functional Concept
T65	Frequency 756 763	diarias
T67	Route 801 811	subcutánea
#55	AnnotatorNotes T67	C1522438; Subcutaneous Route of Drug Administration; Functional Concept
T68	Route 855 863	inhalada
#56	AnnotatorNotes T68	C0205535; Inhalation Route of Drug Administration; Functional Concept
T69	Duration 864 873	≥ 90 días
T70	LIVB 910 918	paciente
#57	AnnotatorNotes T70	C0030705; Patients; Patient or Disabled Group
T71	Duration 957 969	los 12 meses
T72	PHYS 1052 1060	embarazo
#58	AnnotatorNotes T72	C0032961; Pregnancy; Organism Function
T73	PHYS 1121 1130	gestación
#59	AnnotatorNotes T73	C0032961; Pregnancy; Organism Function
T76	Duration 1471 1478	90 días
T77	PHYS 1512 1520	Embarazo
#60	AnnotatorNotes T77	C0032961; Pregnancy; Organism Function
T80	LIVB 1667 1675	paciente
#61	AnnotatorNotes T80	C0030705; Patients; Patient or Disabled Group
T81	PHYS 1870 1878	embarazo
#62	AnnotatorNotes T81	C0032961; Pregnancy; Organism Function
T82	Duration 1911 1922	los 28 días
T83	LIVB 1994 2001	mujeres
#63	AnnotatorNotes T83	C0043210; Woman; Population Group
T84	Neg_cue 2002 2004	no
T85	Duration 2019 2026	28 días
T86	PHYS 2039 2049	concepción
#64	AnnotatorNotes T86	C0009637; Conception; Organism Function | C0015914; Fertilization; Organism Function
T87	PHYS 2061 2071	concepción
#65	AnnotatorNotes T87	C0009637; Conception; Organism Function | C0015914; Fertilization; Organism Function
T88	LIVB 2099 2118	mujeres embarazadas
#66	AnnotatorNotes T88	C0033011; Pregnant Women; Population Group
T89	Duration 2305 2316	los 90 días
T90	LIVB 2352 2361	pacientes
#67	AnnotatorNotes T90	C0030705; Patients; Patient or Disabled Group
T91	Neg_cue 2362 2364	no
T92	Duration 2382 2393	los 28 días
T93	LIVB 2429 2448	mujeres embarazadas
#68	AnnotatorNotes T93	C0033011; Pregnant Women; Population Group
T94	PHYS 2437 2448	embarazadas
#69	AnnotatorNotes T94	C0032961; Pregnancy; Organism Function
T95	PHYS 943 953	embarazada
#70	AnnotatorNotes T95	C0032961; Pregnancy; Organism Function
T96	PHYS 1068 1078	embarazada
#71	AnnotatorNotes T96	C0032961; Pregnancy; Organism Function
T98	PHYS 1706 1716	embarazada
#72	AnnotatorNotes T98	C0032961; Pregnancy; Organism Function
T99	PHYS 1730 1741	fecundación
#73	AnnotatorNotes T99	C0009637; Conception; Organism Function | C0015914; Fertilization; Organism Function
T100	PHYS 2005 2016	embarazadas
#74	AnnotatorNotes T100	C0032961; Pregnancy; Organism Function
T101	PHYS 2365 2376	embarazadas
#75	AnnotatorNotes T101	C0032961; Pregnancy; Organism Function
T102	PHYS 2480 2489	gravídica
#76	AnnotatorNotes T102	C0032961; Pregnancy; Organism Function
T103	PHYS 178 189	embarazadas
#77	AnnotatorNotes T103	C0032961; Pregnancy; Organism Function
T104	PHYS 397 408	embarazadas
#78	AnnotatorNotes T104	C0032961; Pregnancy; Organism Function
T66	Duration 1110 1147	semanas de gestación 8 a 13 (+6 días)
T74	PHYS 2107 2118	embarazadas
#79	AnnotatorNotes T74	C0032961; Pregnancy; Organism Function
A1	Assertion T100 Negated
A2	Assertion T101 Negated
A3	Assertion T37 Contraindicated
A4	Status T47 History_of
#80	AnnotatorNotes T13	C0011854; Diabetes Mellitus, Insulin-Dependent; Disease or Syndrome
#81	AnnotatorNotes T51	C0393124; Continuous subcutaneous infusion of insulin; Therapeutic or Preventive Procedure
#82	AnnotatorNotes T30	C0200354; Urine Specimen Collection; Laboratory Procedure
T75	Observation 1153 1162	anomalías
A5	Assertion T75 Negated
T78	Neg_cue 1149 1152	sin
R1	Combined_with Arg1:T2 Arg2:T4	
R2	Combined_with Arg1:T3 Arg2:T4	
R3	Experiences Arg1:T59 Arg2:T103	
R4	Experiences Arg1:T59 Arg2:T2	
R5	Experiences Arg1:T59 Arg2:T3	
R6	Experiences Arg1:T59 Arg2:T5	
R7	Overlap Arg1:T103 Arg2:T5	
R8	Combined_with Arg1:T7 Arg2:T9	
R9	Combined_with Arg1:T8 Arg2:T9	
R10	Used_for Arg1:T7 Arg2:T10	
R11	Used_for Arg1:T8 Arg2:T10	
R12	Experiences Arg1:T60 Arg2:T7	
R13	Experiences Arg1:T60 Arg2:T8	
R14	Experiences Arg1:T60 Arg2:T104	
R15	Experiences Arg1:T60 Arg2:T11	
R16	Overlap Arg1:T104 Arg2:T11	
R17	Has_Age Arg1:T61 Arg2:T62	
R18	Overlap Arg1:T50 Arg2:T62	
R19	Has_Duration_or_Interval Arg1:T15 Arg2:T63	
T79	PROC 706 715	selección
#83	AnnotatorNotes T79	C0242802; Patient Selection; Research Activity
R20	Before Arg1:T15 Arg2:T79	
R21	Before Arg1:T14 Arg2:T79	
R22	Has_Route_or_Mode Arg1:T16 Arg2:T64	
R23	Has_Frequency Arg1:T16 Arg2:T65	
R24	Used_for Arg1:T16 Arg2:T49	
R25	Used_for Arg1:T18 Arg2:T17	
R26	Has_Route_or_Mode Arg1:T18 Arg2:T67	
R27	Used_for Arg1:T18 Arg2:T51	
R28	Has_Route_or_Mode Arg1:T19 Arg2:T68	
R29	Has_Duration_or_Interval Arg1:T19 Arg2:T69	
T97	PROC 894 903	selección
#84	AnnotatorNotes T97	C0242802; Patient Selection; Research Activity
R30	Before Arg1:T19 Arg2:T97	
T105	Observation 925 953	previsto quedarse embarazada
#85	AnnotatorNotes T105	C0032992; Pregnancy, Planned; Finding
R31	Overlap Arg1:T95 Arg2:T71	
R32	After Arg1:T95 Arg2:T20	
R33	Experiences Arg1:T70 Arg2:T95	
R34	Experiences Arg1:T70 Arg2:T21	
R35	Before Arg1:T21 Arg2:T72	
R36	Experiences Arg1:T70 Arg2:T96	
T106	Observation 1086 1108	feto intrauterino vivo
R37	Overlap Arg1:T96 Arg2:T106	
R38	Has_Duration_or_Interval Arg1:T96 Arg2:T66	
R39	Has_Duration_or_Interval Arg1:T73 Arg2:T66	
R40	Negation Arg1:T78 Arg2:T75	
R41	Overlap Arg1:T106 Arg2:T75	
R42	Overlap Arg1:T75 Arg2:T24	
R46	Experiences Arg1:T70 Arg2:T25	
R47	Experiences Arg1:T70 Arg2:T73	
R48	Experiences Arg1:T70 Arg2:T75	
R49	Overlap Arg1:T106 Arg2:T24	
T107	Result_or_Value 1251 1271	≤ 8,0% (64 mmol/mol)
R51	Has_Result_or_Value Arg1:T52 Arg2:T107	
T108	PROC 1241 1250	selección
#86	AnnotatorNotes T108	C0242802; Patient Selection; Research Activity
R52	Overlap Arg1:T52 Arg2:T108	
R53	Used_for Arg1:T53 Arg2:T26	
R54	Has_Duration_or_Interval Arg1:T26 Arg2:T76	
T109	PROC 1499 1508	selección
#87	AnnotatorNotes T109	C0242802; Patient Selection; Research Activity
R55	Before Arg1:T26 Arg2:T109	
T110	PROC 1651 1660	selección
#88	AnnotatorNotes T110	C0242802; Patient Selection; Research Activity
R59	Overlap Arg1:T30 Arg2:T110	
R60	Overlap Arg1:T54 Arg2:T110	
R61	Overlap Arg1:T77 Arg2:T110	
R64	Overlap Arg1:T29 Arg2:T110	
R65	Location_of Arg1:T55 Arg2:T54	
T111	Result_or_Value 1603 1613	≥ 300 mg/g
R66	Has_Result_or_Value Arg1:T54 Arg2:T111	
R67	Experiences Arg1:T80 Arg2:T33	
R68	Experiences Arg1:T80 Arg2:T98	
R69	Experiences Arg1:T80 Arg2:T34	
R70	Experiences Arg1:T80 Arg2:T99	
R71	Before Arg1:T34 Arg2:T99	
R72	Before Arg1:T99 Arg2:T98	
R73	Experiences Arg1:T80 Arg2:T35	
R74	Before Arg1:T35 Arg2:T99	
R75	Before Arg1:T35 Arg2:T98	
R76	Experiences Arg1:T80 Arg2:T36	
T112	Quantifier_or_Qualifier 1836 1848	concomitante
#89	AnnotatorNotes T112	C0521115; Simultaneous; Temporal Concept
R78	Has_Quantifier_or_Qualifier Arg1:T37 Arg2:T112	
R79	Overlap Arg1:T37 Arg2:T82	
T113	PROC 1936 1945	selección
#90	AnnotatorNotes T113	C0242802; Patient Selection; Research Activity
R80	Before Arg1:T37 Arg2:T113	
T114	PROC 1957 1966	selección
#91	AnnotatorNotes T114	C0242802; Patient Selection; Research Activity
R81	After Arg1:T37 Arg2:T114	
R82	Before Arg1:T37 Arg2:T38	
R83	Experiences Arg1:T83 Arg2:T100	
R84	Negation Arg1:T84 Arg2:T100	
R85	Experiences Arg1:T83 Arg2:T37	
R86	Experiences Arg1:T83 Arg2:T81	
R87	Has_Duration_or_Interval Arg1:T37 Arg2:T85	
R88	Before Arg1:T37 Arg2:T86	
R89	After Arg1:T37 Arg2:T87	
R90	Before Arg1:T37 Arg2:T39	
R91	Experiences Arg1:T83 Arg2:T86	
R92	Experiences Arg1:T83 Arg2:T87	
R93	Experiences Arg1:T88 Arg2:T74	
R94	Experiences Arg1:T88 Arg2:T87	
R95	Before Arg1:T86 Arg2:T100	
R96	Before Arg1:T86 Arg2:T74	
R97	Before Arg1:T86 Arg2:T81	
R98	Experiences Arg1:T88 Arg2:T37	
R100	Location_of Arg1:T43 Arg2:T57	
R105	Before Arg1:T23 Arg2:T57	
R106	Location_of Arg1:T43 Arg2:T23	
R107	Before Arg1:T23 Arg2:T44	
R108	Overlap Arg1:T23 Arg2:T89	
R109	Before Arg1:T23 Arg2:T45	
R110	Experiences Arg1:T90 Arg2:T40	
R111	Experiences Arg1:T90 Arg2:T41	
R112	Experiences Arg1:T90 Arg2:T42	
R113	Experiences Arg1:T90 Arg2:T57	
R114	Experiences Arg1:T90 Arg2:T44	
R115	Experiences Arg1:T90 Arg2:T23	
R116	Experiences Arg1:T90 Arg2:T101	
R117	Negation Arg1:T91 Arg2:T101	
R118	Overlap Arg1:T44 Arg2:T89	
R119	Overlap Arg1:T57 Arg2:T89	
R120	Overlap Arg1:T57 Arg2:T92	
R121	Overlap Arg1:T44 Arg2:T92	
R122	Overlap Arg1:T23 Arg2:T92	
R123	Before Arg1:T23 Arg2:T46	
R124	Experiences Arg1:T93 Arg2:T94	
R125	Experiences Arg1:T93 Arg2:T40	
R126	Experiences Arg1:T93 Arg2:T41	
R127	Experiences Arg1:T93 Arg2:T42	
R128	Experiences Arg1:T93 Arg2:T57	
R129	Experiences Arg1:T93 Arg2:T44	
R130	Experiences Arg1:T93 Arg2:T23	
T115	Quantifier_or_Qualifier 2490 2495	grave
#92	AnnotatorNotes T115	C1547227; Severe - Severity of Illness Code; Intellectual Product
R133	Has_Quantifier_or_Qualifier Arg1:T47 Arg2:T115	
R134	Has_Duration_or_Interval Arg1:T16 Arg2:T69	
R135	Before Arg1:T49 Arg2:T97	
R136	Before Arg1:T17 Arg2:T97	
R137	Has_Duration_or_Interval Arg1:T18 Arg2:T69	
#93	AnnotatorNotes T49	C0021499; Subcutaneous Injections; Therapeutic or Preventive Procedure
R58	Before Arg1:T105 Arg2:T95	
R43	Experiences Arg1:T70 Arg2:T72	
R44	Before Arg1:T87 Arg2:T100	
R45	Before Arg1:T87 Arg2:T81	
R50	Before Arg1:T87 Arg2:T74	
R56	Before Arg1:T57 Arg2:T46	
R57	Before Arg1:T44 Arg2:T46	
#94	AnnotatorNotes T75	C1704258; Abnormality; Finding
A6	Experiencer T59 Patient
A7	Experiencer T60 Patient
A8	Experiencer T61 Patient
T116	Quantifier_or_Qualifier 764 773	múltiples
#95	AnnotatorNotes T116	C0439064; Numerous; Quantitative Concept
R62	Has_Quantifier_or_Qualifier Arg1:T49 Arg2:T116	
A9	Experiencer T70 Patient
A10	Status T95 Future
A11	Experiencer T80 Patient
A12	Experiencer T83 Patient
A13	Experiencer T88 Patient
A14	Experiencer T90 Patient
A15	Experiencer T93 Patient
